FDA grants 'breakthrough therapy' designation to Merck experimental skin cancer drug

Merck & Co. today announced that its experimental drug to treat advanced skin cancer has received breakthrough therapy designation from the Food and Drug Administration, expediting its further development and review.

http://www.nj.com/business/index.ssf/2013/04/mercks_experimental_drug_to_tr.html